title: Growth hormone-releasing activity of hexarelin, a new synthetic hexapeptide, before and during puberty.
abstract: The objective of this study was to verify the GH-releasing activity of a synthetic hexapeptide, hexarelin (HEX), before and during puberty. Ninety-six children (54 boys and 42 girls, aged 4.1-17.4 yr) were studied. Fifty-two of the children were prepubertal, and the other 44 were in pubertal stage II-IV. The GH response to 2 micrograms/kg HEX, iv (n = 56), was higher (P < 0.001) than that induced by 1 microgram/kg GHRH, iv (n = 33). The iv dose of 2.0 micrograms/kg HEX induced a greater GH increase (P < 0.02) than the 1.0 microgram/kg dose. The GH-releasing effect of 10 mg HEX, orally, was greater (P < 0.03) than that of 1.0 microgram/kg GHRH, iv (n = 7). The iv dose of 2 micrograms/kg HEX elicited an increase in GH levels that was higher in pubertal children than in prepubertal children (77.5 +/- 8.5 vs. 39.4 +/- 4.4 micrograms/L; P < 0.001). Before puberty, there was no sex-dependent difference in the GH response to HEX. It increased during puberty (P < 0.05 and P < 0.002 for boys and girls, respectively), when it was higher (P < 0.05) in girls than in boys. In contrast, GH responses to GHRH were not related to sex differences and/or puberty. In conclusion, HEX is a potent and reproducible stimulus of GH secretion in children. The effect of HEX increases in puberty, with girls showing a more marked GH response.
authors.affiliation: Department of Clinical Pathophysiology, University of Turin, Italy.
authors.forename: J
authors.initials: J
authors.lastname: Bellone
authors.forename: G
authors.initials: G
authors.lastname: Aimaretti
authors.forename: E
authors.initials: E
authors.lastname: Bartolotta
authors.forename: L
authors.initials: L
authors.lastname: Benso
authors.forename: B P
authors.initials: BP
authors.lastname: Imbimbo
authors.forename: V
authors.initials: V
authors.lastname: Lenhaerts
authors.forename: R
authors.initials: R
authors.lastname: Deghenghi
authors.forename: F
authors.initials: F
authors.lastname: Camanni
authors.forename: E
authors.initials: E
authors.lastname: Ghigo
mesh_terms: D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D004305:Dose-Response Relationship, Drug; D005260:Female; D013006:Growth Hormone / Q000378:metabolism*; D006133:Growth Substances / Q000494:pharmacology; D006801:Humans; D008297:Male; D009842:Oligopeptides / Q000009:adverse effects / Q000494:pharmacology*; D011627:Puberty / Q000378:metabolism*; D015203:Reproducibility of Results
chemical_list: D006133:Growth Substances; D009842:Oligopeptides; C086184:hexarelin; D013006:Growth Hormone